Follow us on:

Linkedin Facebook

Hardman & Co Investor Forum 26th February 2019

Hardman & Co

Last week we were delighted to host our 15th Investor Forum at the offices of DAC Beachcroft. We welcomed 4 interesting companies to present to an audience of 60 sophisticated investors. The audience had the opportunity to learn more about investing in clean energy, a dividend paying gold miner, and two distinct health care companies at different commercial stages.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Hardman & Co

Shield Therapeutics driving Growth and Financial Stability

Shield Therapeutics plc, a leader in specialty pharma, boosts ACCRUFeR® sales for iron deficiency in the US while optimizing financial strategies for growth.
Hardman & Co

Shield Therapeutics: Strong H1 ’24 Sales and Cashflow Outlook for H2 ’25

Hardman & Co

Shield Therapeutics accelerating effectiveness of enlarged sales team

Hardman & Co

Shield Therapeutics share price hitting highest level since November 2022

Hardman & Co

Anglo Asian Mining copper production to explode over the medium term (LON:AAZ)

Anglo Asian Mining at a key moment in its evolution (VIDEO)

Latest interviews

View all interviews 

Company Presentations

View all Company Presentations

Brokers Talk

View all Broker Talk

FTSE 100 News

Search

Search

Green News

View all Sustainable sectors, Plcs and news  

Q&A's

View all Question and Answers

Funds

View all Funds, Market Insights and news

UK Broker Ratings

Hardman & Co

Don't Miss Our News Alerts

Subscribe Free

Find us on:

Linkedin Facebook

Useful links

Disclaimer

You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular stock, share, security, portfolio of securities, transaction, investment strategy, or other matter. We openly disclose that we and our contributors may have interests in investments and/or providers of services referred to within the website and that we receive remuneration from certain of the companies referred to on this website.

© 2025 – DirectorsTalk Interviews. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.